NSIM
BLUE

North Star Investment Management’s bluebird bio BLUE Stock Holding History

North Star Investment Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12
Closed -$21K – 1064
2017
Q3 		$21K Hold
12
– – ﹤0.01% 710
2017
Q2 		$16K Hold
12
– – ﹤0.01% 740
2017
Q1 		$14K Hold
12
– – ﹤0.01% 743
2016
Q4 		$9K Hold
12
– – ﹤0.01% 757
2016
Q3 		$10K Hold
12
– – ﹤0.01% 628
2016
Q2 		$6K Hold
12
– – ﹤0.01% 674
2016
Q1 		$6K Buy
+12
New +$7.37K ﹤0.01% 636

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

North Star Investment Management's BLUE Position: Q4 2017 in Review

North Star Investment Management sold out of bluebird bio (BLUE) in Q4 2017, closing a stake of 12 shares — an estimated $21K sold.

North Star Investment Management first reported a position in BLUE in Q1 2016 and held it in 7 quarters. The position peaked at $21K in Q3 2017. 296 funds tracked by Wall St. Rank hold BLUE as of Q4 2017.

  • North Star Investment Management reported no remaining bluebird bio position as of Q4 2017 after selling out during the quarter.
  • North Star Investment Management sold 12 bluebird bio shares in Q4 2017, an estimated $21K.
  • North Star Investment Management first reported a position in bluebird bio in Q1 2016 and held it in 7 quarters.
  • North Star Investment Management's bluebird bio position peaked at $21K in Q3 2017.
  • 296 funds tracked by Wall St. Rank held bluebird bio as of Q4 2017.

Based on North Star Investment Management's 13F filing for Q4 2017, filed 11 Jan 2018.